Similar Papers

Paper Title
Journal
Date
Author
Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.
Daniel L Edmonston ... Andrew M South
Advances in Chronic Kidney Disease | VOL. 27
Daniel L Edmonston, et. al.Daniel L Edmonston ... Andrew M South
04 Jul 2020
Human recombinant soluble ACE2 in severe COVID-19
Alexander Zoufaly ...
The Lancet Respiratory Medicine | VOL. 8
Alexander Zoufaly, et. al.Alexander Zoufaly ...
24 Sep 2020
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Junyi Guo ... Zheng Huang
Journal of the American Heart Association | VOL. 9
Junyi Guo, et. al.Junyi Guo ... Zheng Huang
01 Apr 2020
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy.
Daniela Tomasoni ... Marco Metra
European journal of heart failure | VOL. 23
Daniela Tomasoni, et. al.Daniela Tomasoni ... Marco Metra
25 Jan 2021
View more papers

More From: ESC heart failure

Paper Title
Journal
Date
Author
Growth differentiation factor-15 and N-terminal pro-BNP in acute heart failure with preserved ejection fraction.
Yoichiro Otaki ... Masafumi Watanabe
ESC heart failure | VOL. -
Yoichiro Otaki, et. al.Yoichiro Otaki ... Masafumi Watanabe
03 Feb 2025
Validation of a biomarker-based mortality score for cardiogenic shock patients: Comparison with a clinical risk score.
Elina Hynninen ... Johan Lassus
ESC heart failure | VOL. -
Elina Hynninen, et. al.Elina Hynninen ... Johan Lassus
02 Feb 2025
Explainable machine learning and online calculators to predict heart failure mortality in intensive care units.
An‐Tian Chen ... Yuhui Zhang
ESC heart failure | VOL. 12
An‐Tian Chen, et. al.An‐Tian Chen ... Yuhui Zhang
01 Feb 2025
-
-
ESC Heart Failure | VOL. -
--
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.